Documenti analoghi

• In vitro PK/PD modeling of tyrosine kinase inhibitors in non‐small cell lung cancer cell lines
  di: Linda Wanika, et al.
  Pubblicazione: (2024)
• Multi‐omics predictive model based on clinical, radiomic and genomic features for predicting the response of limited‐stage small cell lung cancer to definitive chemoradiotherapy
  di: Li Li, et al.
  Pubblicazione: (2024)
• CXCR5 and TLR4 signals synergistically enhance non‐small cell lung cancer progression
  di: Ji Hye Shin, et al.
  Pubblicazione: (2024)
• Immune‐related adverse events in non‐small cell lung cancer: Occurrence, mechanisms and therapeutic strategies
  di: Xuwen Lin, et al.
  Pubblicazione: (2024)
• Engineered lung cell targeting and SLC7A11 siRNA expressing bacterial extracellular vesicles impair the progression of none‐small cell lung cancer
  di: Xiao‐dan Wan, et al.
  Pubblicazione: (2025)